Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials

K. Reich, A. M. DeLozier, F. P. Nunes, J. P. Thyssen, L. F. Eichenfield, A. Wollenberg, J. A. Ross Terres, S. D. Watts, Y. F. Chen, E. L. Simpson, J. I. Silverberg

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences